During the past decade, Optimal Research conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 16 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 12 clinical trials were completed. i.e. 70.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Optimal Research" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 9 trials, followed by "ModernaTX, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Altimmune, Inc." with 2 trials sponsored and "Emergent BioSolutions" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Optimal Research" #1 collaborator was "Accelovance" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Benu BioPharma, LLC" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Optimal Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Optimal Research" are "Cytomegalovirus Infection" (3 trials), "Dengue Fever" (2 trials), "Healthy Volunteers" (2 trials), "Influenza, Human" (2 trials) and "Respiratory Syncytial Viruses" (2 trials). Many other conditions were trialed in "Optimal Research" in a lesser frequency.

Most popular intervention types in "Optimal Research" are "Biological" (33 trials), "Other" (8 trials), "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Ad26.COV2.S" (3 trials), "mRNA-1647" (3 trials), "Ad26.RSV.preF-based vaccine" (2 trials) and "BioThrax" (2 trials). Other intervention names were less common.

The vast majority of trials in "Optimal Research" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Optimal Research". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Optimal Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Optimal Research, 11 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".